Sharp Corporation has demonstrated that Plasmacluster Ions reduce activity of the highly fatal and highly pathogenic airborne H5N1 avian influenza (“bird flu”) virus by 99%. This research was conducted in collaboration with Retroscreen Virology, Ltd., an organization which was established by one of the world’s leading authorities on virology, Professor John S. Oxford of the University of London School of Medicine & Dentistry, and which works in compliance with Good Laboratory Practice*3 (GLP). Among the diverse range of air purification technologies available, Plasmacluster Ions are the first in the world to have been proven effective against this virus.
Here's the full story.